Literature DB >> 2783334

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

A Waage1, P Brandtzaeg, A Halstensen, P Kierulf, T Espevik.   

Abstract

Serum samples from patients with meningococcal disease were examined for the presence of IL-6, TNF-alpha, and LPS. Median serum concentration of IL-6 was 1,000 times higher in patients with septic shock (189 ng/ml) than in patients with bacteriaemia, meningitis, or combined septic shock and meningitis. 11 of 21 patients with serum levels greater than 3.0 ng/ml died, whereas all 58 patients with serum levels at less than or equal to 3.0 ng/ml, survived. All four patients with serum IL-6 levels greater than 750 ng/ml, died. IL-1 was detected in serum from three patients who also had high serum levels of IL-6, TNF-alpha, and LPS, and rapidly fatal courses. IL-6 appeared to be released into serum later than TNF-alpha, and was detected in serum for up to 36 h. The half-life of IL-6 and TNF-alpha was calculated to be 103 +/- 27 min and 70 +/- 11 min, respectively. These data indicate that a complex pattern of cytokines exists in serum from patients with meningococcal septic shock, and that the release of IL-6 and IL-1, in addition to TNF-alpha, is associated with fatal outcome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783334      PMCID: PMC2189201          DOI: 10.1084/jem.169.1.333

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Phase I trial of recombinant interferon gamma in cancer patients.

Authors:  S Vadhan-Raj; A Al-Katib; R Bhalla; L Pelus; C F Nathan; S A Sherwin; H F Oettgen; S E Krown
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

4.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Molecular cloning and expression of hybridoma growth factor in Escherichia coli.

Authors:  J P Brakenhoff; E R de Groot; R F Evers; H Pannekoek; L A Aarden
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

7.  A rapid biologic assay for the detection of interleukin 1.

Authors:  P J Conlon
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

8.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

10.  Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.

Authors:  C P Maury; A M Teppo
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  290 in total

1.  Activation of extracellular signal-related protein kinases 1 and 2 of the mitogen-activated protein kinase family by lipopolysaccharide requires plasma in neutrophils from adults and newborns.

Authors:  S Bonner; S R Yan; D M Byers; R Bortolussi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Hemofiltration in septic patients is not able to alter the plasma concentration of cytokines therapeutically.

Authors:  M van Deuren; J W van der Meer
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

3.  Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Authors:  Zoltán H Németh; Balázs Csóka; Jeanette Wilmanski; Dazhong Xu; Qi Lu; Catherine Ledent; Edwin A Deitch; Pál Pacher; Zoltán Spolarics; György Haskó
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

4.  Leukocyte function-associated antigen-1 deficiency impairs responses to polymicrobial sepsis.

Authors:  Jia-Ren Liu; Xiaohui Han; Sulpicio G Soriano; Koichi Yuki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

5.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 6.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

7.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

8.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

9.  Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.

Authors:  M van Deuren; B J van Dijke; R J Koopman; A M Horrevorts; J F Meis; F W Santman; J W van der Meer
Journal:  BMJ       Date:  1993-05-08

10.  Diminished cord blood lymphocyte L-selectin expression in neonatal bacterial infection.

Authors:  C Bührer; U Luxenburger; B Metze; E Kattner; G Henze; J W Dudenhausen; M Obladen
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.